The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FDG-PET/CT response and prediction of pathological response to neoadjuvant nivolumab and ipilimumab for clinical stage III melanoma.
 
Milton Jose De Barros E Silva
No Relationships to Disclose
 
Monique Celeste Tavares
No Relationships to Disclose
 
Joao Paulo S. N. Lima
No Relationships to Disclose
 
Antonio C. Buzaid
Stock and Other Ownership Interests - Agenus
Honoraria - AstraZeneca; Blau; BMS Brazil; Dr. Reddy's Laboratories; Lilly; MSD Oncology; Novartis; Pfizer; Roche/Genentech; United Medical
Consulting or Advisory Role - AstraZeneca; Blau Farmaceutica; BMS Brazil; Dr. Reddy's Laboratories; Lilly; MSD Oncology; Novartis; Pfizer; Roche/Genentech; United Medical
Speakers' Bureau - AstraZeneca; BMS Brazil; Dr. Reddy's Laboratories; Lilly; MSD Oncology; Novartis; Pfizer; Roche/Genentech; United Medical
Research Funding - AstraZeneca (Inst); BMS Brazil (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - BMS Brazil; MSD Oncology; Novartis; Pfizer; Roche
 
Daniel Garcia
No Relationships to Disclose
 
Veridiana Pires De Camargo
No Relationships to Disclose
 
Andre Molina
No Relationships to Disclose
 
Eduardo Bertolli
No Relationships to Disclose
 
Matheus Lobo
No Relationships to Disclose
 
Alexander Christopher Jonathan Van Akkooi
Consulting or Advisory Role - 4SC (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Merck/Pfizer (Inst); MSD Oncology (Inst); Novartis (Inst); Pierre Fabre (Inst); Provectus Biopharmaceuticals; Sanofi (Inst); Sirius Medical (Inst)
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Merck/Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis
 
Clovis Pinto
No Relationships to Disclose
 
Rafaela Brito De Paula
No Relationships to Disclose
 
Eduardo Lima
No Relationships to Disclose
 
José Augusto Rinck
No Relationships to Disclose
 
Joao Duprat
No Relationships to Disclose